Lee Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 0.505107 million compared to USD 0.023547 million a year ago. Basic loss per share from continuing operations was USD 0.03.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0051 USD | +8.51% |
|
+6.25% | -80.23% |
26/06 | RONN Inc. Provides Update on JV Talks With Erisha EV | CI |
28/05 | RONN Inc. Signs Strategic Partnership Engagement Letter with Tobique First Nations Canada | CI |
1st Jan change | Capi. | |
---|---|---|
-80.23% | 48.95L | |
+4.67% | 6.93TCr | |
-4.43% | 5.97TCr | |
-12.98% | 5.97TCr | |
+29.51% | 5.31TCr | |
+18.21% | 5.2TCr | |
+5.33% | 5.13TCr | |
+38.08% | 4.48TCr | |
+27.28% | 4.37TCr | |
+66.57% | 3.85TCr |
- Stock Market
- Equities
- RONN Stock
- News RONN Inc.
- Lee Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022